About Credence medsystems, inc.
Credence MedSystems, Inc. is a leading drug delivery company that is revolutionizing the way drugs are administered to patients. The company has developed innovative delivery systems that help differentiate products while preserving trusted processes.
Credence MedSystems was founded in 2013 by John Merhige and Jeff Tillack, who saw an opportunity to improve drug delivery systems. They recognized that traditional methods of administering drugs were often inconvenient and could lead to errors or complications. They set out to create a better solution, one that would be easy for patients and healthcare providers alike.
The result was the Credence Companion® Safety Syringe System, which features a unique locking mechanism that prevents accidental needlestick injuries. This system also allows for precise dosing and reduces waste, making it more cost-effective than traditional syringes.
Since then, Credence MedSystems has continued to innovate with new products like the Dual Chamber Syringe (DCS), which allows for the mixing of two components immediately prior to injection. This eliminates the need for multiple steps and reduces the risk of contamination or error.
One of the key advantages of Credence MedSystems' products is their compatibility with existing manufacturing processes. This means that pharmaceutical companies can easily integrate these new delivery systems into their production lines without significant changes or disruptions.
In addition to improving safety and convenience for patients and healthcare providers, Credence MedSystems' products also offer benefits in terms of regulatory compliance. The company's syringes meet all relevant standards for quality control and traceability, ensuring that they can be used in clinical trials or commercial applications with confidence.
Overall, Credence MedSystems is setting a new standard in drug delivery through its innovative solutions and commitment to quality. By partnering with this forward-thinking company, pharmaceutical companies can differentiate their products while improving patient outcomes at the same time.